Avik Dutta

9PUBLICATIONS
16CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 28, 2026
PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications.

|Nov 27, 2023
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.

Yue Yang, Salar Abbas, Mohammad A Sayem

|May 09, 2023
THEMIS increases TCR signaling in CD4+CD8+ thymocytes by inhibiting the activity of the tyrosine phosphatase SHP1.

Seeyoung Choi, Jan Lee, Teri Hatzihristidis

|Apr 17, 2023
GRB2 promotes thymocyte positive selection by facilitating THEMIS-mediated inactivation of SHP1.

Seeyoung Choi, Teri Hatzihristidis, Guillaume Gaud

|Sep 13, 2022
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.

Mohammed Ferdous-Ur Rahman, Yue Yang, Bao T Le

|Dec 30, 2021
Epigenetic regulation of T cell development.

Avik Dutta, Harini Venkataganesh, Paul E Love

Pageof 2

Frequent Collaborators

5 joint publications

Golam Mohi

2 joint publications

Mohammad A Sayem

2 joint publications

Seeyoung Choi

2 joint publications

Guillaume Gaud